By contrast, levels of active Casp6 are not different in NCI, MCI or AD ERC, Tau∆Casp6 is increased in AD ERC relative to NCI ERC levels, but PHF-1 and Aβ levels are increased in AD ERC compared to both NCI and MCI ERC. This evidence concerns the gene CASP6 and Alzheimer disease.